Developing models to predict the progression of Parkinson's disease
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
This study is working on smart computer models to help predict how Parkinson's disease changes over time, so that patients can get better treatment options and clinical trials can be more effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10459490 on NIH RePORTER |
What this research studies
This research focuses on creating advanced mathematical models that can predict how Parkinson's disease progresses over time. By utilizing data-driven algorithms, the project aims to enhance the design of clinical trials, making them more efficient and targeted. Patients will benefit from improved understanding of their disease progression, which could lead to better treatment options. The research seeks to establish a solid evidence base for using these models in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Parkinson's disease who are interested in participating in clinical trials.
Not a fit: Patients with early-stage Parkinson's disease or those not interested in clinical trials may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for patients with Parkinson's disease.
How similar studies have performed: While disease progression modeling has been widely adopted in other areas, its specific application to Parkinson's disease is still emerging and has not been extensively tested.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Kieburtz, Karl D. — University of Rochester
- Study coordinator: Kieburtz, Karl D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.